Bicarbonate

Bicarbonate

SCHEMBL11468689

O=C(O)O.O=C(c1ccccc1)C1CC1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.54
CPB1 P15086 1/20 0.54
KMT2A Q03164 3/20 0.53
MGLL Q99685 2/20 0.53
MEN1 O00255 2/20 0.53
HSD11B1 P28845 1/20 0.53
SLC18A3 Q16572 2/20 0.51
KCNH2 Q12809 1/20 0.50
MCL1 Q07820 1/20 0.50
ALDH1A1 P00352 1/20 0.50
SRD5A2 P31213 1/20 0.50
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18428493 0.98 HTR2A (0.56) HTR2ACPB1KMT2AMGLLMEN1
SCHEMBL324342 0.98 HTR2A (0.56) HTR2ACPB1KMT2AMGLLMEN1
SCHEMBL3515355 0.91 NPC1 (0.52) HTR2ACPB1KMT2AMGLLMEN1
SCHEMBL439217 0.91 NPC1 (0.52) HTR2ACPB1KMT2AMGLLMEN1
SCHEMBL407216 0.91 NPC1 (0.52) HTR2ACPB1KMT2AMGLLMEN1
Acetic Acid SCHEMBL2762930 0.91 HTR2A (0.51) HTR2ACPB1KMT2AMGLLMEN1
SCHEMBL26883 0.89 SLC18A3 (0.51) HTR2ACPB1KMT2AMGLLMEN1
Bicarbonate SCHEMBL6612782 0.89 SRD5A2 (0.65) HTR2ACPB1KMT2AMGLLMEN1
SCHEMBL965420 0.88 SRD5A2 (0.63) HTR2ACPB1KMT2AMGLLMEN1
SCHEMBL3113279 0.88 SRD5A2 (0.58) HTR2ACPB1KMT2AMGLLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0012366-A1 3,4-Diaza-bicyclo(4.1.0)hepten-2-ones-5, process for their preparation and therapeutical compositions containing them BASF Aktiengesellschaft (DE) 1980-06-25 EP disclosed